Dextromethorphan FDA Alerts
The FDA Alerts below may be specifically about dextromethorphan or relate to a group or class of drugs which include dextromethorphan.
MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. Following is a list of possible medication recalls, market withdrawals, alerts and warnings.
Recent FDA Alerts for dextromethorphan
Dextromethorphan
FDA issued a Talk Paper to notify the public about the abuse of dextromethorphan (DXM), an ingredient found in many over-the-counter (OTC) cough and cold remedies. The agency is working with other health and law enforcement authorities to address this serious issue and warn the public of potential harm, after five recently reported deaths of teenagers that may be associated with the consumption of powdered DXM sold in capsules.[May 20, 2005 - Talk Paper - FDA]
More dextromethorphan resources
- Dextromethorphan Consumer Information
- Children's Cough DM Consumer Information
- Children's Robitussin 12 Hour Cough Relief Consumer Information
- Cough DM Consumer Information
- Cough Relief Consumer Information
- Father John's Medicine Consumer Information
- Robitussin 12 Hour Cough Relief Consumer Information
- Robitussin Long-Acting CoughGels Consumer Information
- Benylin Pediatric Formula Advanced Consumer Information
- Creo-Terpin Advanced Consumer Information
- Father John's Medicine Advanced Consumer Information
- Miltuss Advanced Consumer Information
- Nycoff Advanced Consumer Information
- Robafen Cough Advanced Consumer Information
- Robitussin (Dextromethorphan Oral) Advanced Consumer Information
- Simply Cough Advanced Consumer Information
- St. Joseph Advanced Consumer Information
- Dextromethorphan AHFS DI Monograph